MOLECULAR DOCKING STUDIES ON THE THERAPEUTIC TARGETS OF ALZHEIMER DISEASE (ACHE AND BCHE) USING NATURAL BIOACTIVE ALKALOIDS Read More > November 1, 2016
Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging Read More > October 31, 2016
Activation of 5-HT2A/2C receptors reduces the excitability of cultured cortical neurons Read More > October 6, 2016
The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells Read More > September 14, 2016
The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies Read More > August 28, 2016
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors Read More > August 17, 2016
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration Read More > August 16, 2016
Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study Read More > August 8, 2016
